Plain-English translation of NCT06748352 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This pilot trial is testing a flexible robotic assistance system called FASTER to help doctors perform endoscopic submucosal dissection (ESD)—a minimally invasive procedure to remove early-stage stomach cancer. Researchers want to see if the robotic system can make the procedure safer by reducing injuries to the stomach muscle and faster by reducing the time needed to complete it. You would be randomly assigned to receive either the robot-assisted procedure or the standard procedure without robotic help.
ESD is an effective, less invasive way to treat early stomach cancer, but it requires precise tissue handling to avoid damaging the deeper muscle layers of the stomach. This robotic system was designed to give doctors better control and visibility during the procedure, potentially making it safer and more efficient.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive standard ESD surgery or ESD with robotic assistance. The procedure itself is performed under general anesthesia, so you will be asleep during the operation. After the procedure, you will keep a diary of any symptoms you experience and follow up with the research team to monitor your recovery and healing.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
China